Patents by Inventor Joshua Costin

Joshua Costin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Optimized dengue virus entry inhibitory peptide (10AN)
    Patent number: 8637472
    Abstract: The invention relates peptide entry inhibitors and methods of determining such inhibitors that are bindable to regions of viruses having class II E proteins, such as the dengue virus E protein, as candidates for in vivo anti-viral compounds.
    Type: Grant
    Filed: July 11, 2008
    Date of Patent: January 28, 2014
    Assignees: University of Washington Through Its Center for Commercialization, Florida Gulf Coast University
    Inventors: Scott F. Michael, Sharon Isern, Joshua Costin, Vaikuntanath Samudrala, Ekachai Jenwitheesuk
  • Optimized dengue virus entry inhibitory peptide (DN81)
    Patent number: 8541377
    Abstract: The invention relates peptide entry inhibitors and methods of determining such inhibitors that are bindable to regions of viruses having class II E proteins, such as the dengue virus E protein, as candidates for in vivo anti-viral compounds.
    Type: Grant
    Filed: July 11, 2008
    Date of Patent: September 24, 2013
    Assignee: Florida Gulf Coast University
    Inventors: Scott F. Michael, Sharon Isern, Robert Garry, Ram Samudrala, Joshua Costin, Ekachai Jenwitheesuk
  • OPTIMIZED DENGUE VIRUS ENTRY INHIBITORY PEPTIDE (10AN)
    Publication number: 20110178003
    Abstract: The invention relates peptide entry inhibitors and methods of determining such inhibitors that are bindable to regions of viruses having class II E proteins, such as the dengue virus E protein, as candidates for in vivo anti-viral compounds.
    Type: Application
    Filed: July 11, 2008
    Publication date: July 21, 2011
    Applicant: FLORIDA GULF COAST UNIVERSITY
    Inventors: Scott F. Michael, Sharon Isern, Joshua Costin, Ram Samudrala, Ekachai Jenwitheesuk
  • OPTIMIZED DENGUE VIRUS ENTRY INHIBITORY PEPTIDE (DN81)
    Publication number: 20110112031
    Abstract: The invention relates peptide entry inhibitors and methods of determining such inhibitors that are bindable to regions of viruses having class II E proteins, such as the dengue virus E protein, as candidates for in vivo anti-viral compounds.
    Type: Application
    Filed: July 11, 2008
    Publication date: May 12, 2011
    Applicant: FLORIDA GULF COAST UNIVERSITY
    Inventors: Scott F. Michael, Sharon Isern, Robert Garry, Ram Samudrala, Joshua Costin, Ekachai Jenwitheesuk
  • ANTI-VIRAL PROPERTIES OF ZOSTERIC ACID AND RELATED MOLECULES
    Publication number: 20110100371
    Abstract: The invention relates chemical compound entry inhibitors and methods of determining such inhibitors that interact with regions of viruses, such as the dengue virus, as candidates for in vivo anti-viral compounds.
    Type: Application
    Filed: July 11, 2008
    Publication date: May 5, 2011
    Applicant: FLORIDA GULF COAST UNIVERSITY
    Inventors: Scott F. Michael, Sharon Isern, Joshua Costin